Status:
COMPLETED
Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
18-120 years
Brief Summary
RATIONALE: Studying samples of cells in the laboratory from patients with cancer may help identify biomarkers related to cancer. It may also help doctors learn how patients respond to treatment. PURP...
Detailed Description
OBJECTIVES: * To analyze the expression of a variety of informative molecules using a unique high-resolution flow cytometric immunophenotyping technology in samples from patients with chronic lymphoc...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Stored frozen viable cells from patients with chronic lymphocytic leukemia treated on clinical trial ECOG-2997
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
April 17 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 17 2012
Estimated Enrollment :
225 Patients enrolled
Trial Details
Trial ID
NCT00899873
Start Date
April 17 2012
End Date
July 17 2012
Last Update
May 17 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.